ChronoScale
CHRN
19.77
+0.49
+2.54%
ChronoScale
US · CHRN
#2563 by market cap
Listed 1970
19.77
+0.49
+2.54%
Live - 5344 symbols - heartbeat 430s ago
· 2026-10-08 08:12
Pre-market
19.65
-0.60%
After-hours
20.00
+1.16%
- Market cap
- 2.88B
- P/E (TTM)i
- -54.92
- P/Bi
- 16.00
- EPSi
- -0.36
- Div yieldi
- 0.00%
- 52W posi
- 61%
Reader sentiment
Are you bullish or bearish on CHRN?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 10.68, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 2 years
Latest year -15.14% YoY
Margins
- Gross margin
- -23.86%
- Operating margin
- -51.53%
- Net margin
- -70.28%
Key ratios & quality
- Enterprise valuei
- 2.94B
- Altman Z-Scorei
- 10.68
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2025 | 2026 |
|---|---|---|
| Revenue | 84.38M | 71.60M |
| Gross profit | -30.93M | -17.09M |
| Selling & admin expenses | 24.81M | 19.81M |
| Research & development | -- | -- |
| Operating profit | -55.75M | -36.90M |
| Pretax profit | -72.73M | -49.30M |
| Tax | 0 | 0 |
| Net profit | -72.73M | -50.32M |
| Basic EPS | -1 | 0 |
| Diluted EPS | -0.51 | -0.36 |
| Line item | 2025-11 | 2026-05 |
|---|---|---|
| Revenue | -- | -- |
| Gross profit | -- | -- |
| Selling & admin expenses | -- | -- |
| Research & development | -- | -- |
| Operating profit | -- | -- |
| Pretax profit | -- | -- |
| Tax | -- | -- |
| Net profit | -- | -- |
| Basic EPS | -- | -- |
| Diluted EPS | -- | -- |
Balance sheet
| Line item | 2025 | 2026 |
|---|---|---|
| Total current assets | 6.41M | 44.25M |
| Cash & ST investments | 2.40M | 9.66M |
| Inventory | -- | -- |
| Total assets | 304.20M | 325.87M |
| Total current liabilities | 157.63M | 86.89M |
| Short-term debt | 149.50M | 69.07M |
| Long-term debt | 12.00M | 474.00K |
| Total liabilities | 228,048,000.00 | 145,849,000.00 |
| Total equity | 76.15M | 180.03M |
| Retained earnings | -149.14M | -199.46M |
| Line item | 2025-11 | 2026-05 |
|---|---|---|
| Total current assets | 9.59M | 44.25M |
| Cash & ST investments | 2.00K | 9.66M |
| Inventory | -- | -- |
| Total assets | 271.80M | 325.87M |
| Total current liabilities | 96.75M | 86.89M |
| Short-term debt | 91.88M | 69.07M |
| Long-term debt | 12.00M | 474.00K |
| Total liabilities | 173,318,000.00 | 145,849,000.00 |
| Total equity | 98.48M | 180.03M |
| Retained earnings | -- | -199.46M |
Cash flow
| Line item | 2025 | 2026 |
|---|---|---|
| Operating cash flow | -7.22M | 39.07M |
| Depreciation & amortization | 80.66M | 60.34M |
| Free cash flow | -8.60M | 12.19M |
| Dividends paid | -- | -- |
| Stock buybacks / issuance | 0 | 15.00M |
| Ending cash balance | 2.40M | 9.66M |
| Line item | 2025-11 | 2026-05 |
|---|---|---|
| Operating cash flow | -- | -- |
| Depreciation & amortization | -- | -- |
| Free cash flow | -- | -- |
| Dividends paid | -- | -- |
| Stock buybacks / issuance | -- | -- |
| Ending cash balance | -- | -- |
Returns & efficiency
| Line item | 2025 | 2026 |
|---|---|---|
| ROE %i | -95.51 | -39.29 |
| ROA %i | -23.91 | -15.97 |
| ROIC %i | -18.69 | -13.66 |
| 5-year avg ROE %i | -- | -- |
| EBIT margin %i | -65.58 | -55.47 |
| FCF / sales %i | -- | 17.03 |
| Current ratioi | 0.04 | 0.51 |
| Quick ratioi | 0.04 | 0.26 |
| Debt / assetsi | 72.29 | 37.00 |
| LT debt / equityi | 92.47 | 28.60 |
| Interest coveragei | -3.18 | -4.14 |
| Revenue CAGR (3Y) %i | -- | -- |
| Net income CAGR (3Y) %i | -- | -- |
| FCF CAGR (3Y) %i | -- | -- |
| Line item | 2025-11 | 2026-05 |
|---|---|---|
| ROE %i | -- | -39.29 |
| ROA %i | -- | -15.97 |
| ROIC %i | -- | -13.66 |
| 5-year avg ROE %i | -- | -- |
| EBIT margin %i | -- | -55.47 |
| FCF / sales %i | -- | 17.03 |
| Current ratioi | 0.10 | 0.51 |
| Quick ratioi | 0.09 | 0.26 |
| Debt / assetsi | 61.98 | 37.00 |
| LT debt / equityi | 77.75 | 28.60 |
| Interest coveragei | -- | -4.14 |
| Revenue CAGR (3Y) %i | -- | -- |
| Net income CAGR (3Y) %i | -- | -- |
| FCF CAGR (3Y) %i | -- | -- |
Revenue breakdown most recent period
Business
Single segment100.00%
Region
United States100.00%
Quote time 2026-10-08 08:12:26 · For reference only, not investment advice and not tailored to your situation.